Moody's Investors Service has assigned an "Aa2" rating to Rochester, Minn.-based Mayo Clinic's proposed $300 million of series 2016 fixed rate revenue bonds.
The rating assignment is based on a number of factors, including Mayo's large size, strong fundraising ability and demonstrated national and international draw for patients.
The outlook is stable, reflecting Moody's Investors Service's expectation that Mayo is positioned to continue to generate adequate adjusted operating margins and sustain liquidity ratios to support its research needs and absorb its capital spending.